UBS Upgrades Moderna (MRNA) to Buy, 'Pipeline underappreciated'

June 26, 2023 4:07 AM EDT Send to a Friend
(Updated - June 26, 2023 5:19 AM EDT)

UBS analyst Eliana Merle upgraded Moderna (NASDAQ: MRNA) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login